| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |